STRATEC Biomedical AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution


STRATEC Biomedical AG

12.10.2018 / 11:10
Dissemination of a Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Notification of Major Holdings

1. Details of issuer
STRATEC Biomedical AG
Gewerbestr. 37
75217 Birkenfeld
Germany

2. Reason for notification
X Acquisition/disposal of shares with voting rights
  Acquisition/disposal of instruments
  Change of breakdown of voting rights
X Other reason:
Voluntary Group Disclosure due to threshold crossing within corporate structure

3. Details of person subject to the notification obligation
Name: City and country of registered office:
Ameriprise Financial, Inc. Wilmington, Delaware
United States of America (USA)

4. Names of shareholder(s)
holding directly 3% or more voting rights, if different from 3.
Threadneedle Investment Funds ICVC

5. Date on which threshold was crossed or reached:
06 Oct 2018

6. Total positions
  % of voting rights attached to shares
(total of 7.a.)
% of voting rights through instruments
(total of 7.b.1 + 7.b.2)
total of both in %
(7.a. + 7.b.)
total number of voting rights of issuer
Resulting situation 6.66 % 0.00 % 6.66 % 11962495
Previous notification 6.01 % 0.00 % 6.01 % /

7. Notified details of the resulting situation
a. Voting rights attached to shares (Sec.s 33, 34 WpHG)
ISIN absolute in %
  direct
(Sec. 33 WpHG)
indirect
(Sec. 34 WpHG)
direct
(Sec. 33 WpHG)
indirect
(Sec. 34 WpHG)
DE000STRA555 0 797089 0.00 % 6.66 %
Total 797089 6.66 %

b.1. Instruments according to Sec. 38 para. 1 No. 1 WpHG
Type of instrument Expiration or maturity date Exercise or conversion period Voting rights absolute Voting rights in %
%
    Total %

b.2. Instruments according to Sec. 38 para. 1 No. 2 WpHG
Type of instrument Expiration or maturity date Exercise or conversion period Cash or physical settlement Voting rights absolute Voting rights in %
%
      Total %

8. Information in relation to the person subject to the notification obligation
  Person subject to the notification obligation is not controlled and does itself not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer (1.).
X Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:

Name % of voting rights (if at least held 3% or more) % of voting rights through instruments (if at least held 5% or more) Total of both (if at least held 5% or more)
Ameriprise Financial, Inc. % % %
Ameriprise International Holdings GmbH % % %
Threadneedle Asset Management Holdings SARL % % %
Threadneedle Holdings Limited % % %
TAM UK Holdings Limited % % %
Threadneedle Asset Management Holdings Limited % % %
TC Financing Limited % % %
Threadneedle Asset Management Limited 6.66 % % 6.66 %
 
Ameriprise Financial, Inc. % % %
Ameriprise International Holdings GmbH % % %
Threadneedle Asset Management Holdings SARL % % %
Threadneedle Holdings Limited % % %
TAM UK Holdings Limited % % %
Threadneedle Asset Management Holdings Limited % % %
TC Financing Limited % % %
Threadneedle Investment Services Limited 3.87 % % %
 
Ameriprise Financial, Inc. % % %
Ameriprise International Holdings GmbH % % %
Threadneedle Asset Management Holdings SARL % % %
Threadneedle Management Luxembourg SA % % %

9. In case of proxy voting according to Sec. 34 para. 3 WpHG

Date of general meeting:
Holding position after general meeting: % (equals voting rights)

10. Other explanatory remarks:
Voluntary Group Disclosure due to threshold crossing within corporate structure 



12.10.2018 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this
back